title: Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?
authors.affiliation: Department of Pharmacy, University of Michigan Health System, Ann Arbor, Michigan, USA bernmari@med.umich.edu.
authors.forename: Bernard L
authors.initials: BL
authors.lastname: Marini
authors.affiliation: Department of Pharmacy, University of Michigan Health System, Ann Arbor, Michigan, USA.
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Perissinotti
authors.affiliation: Department of Pharmacy, Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
authors.forename: Angela M
authors.initials: AM
authors.lastname: Huang
authors.affiliation: Department of Pharmacy, University of Michigan Health System, Ann Arbor, Michigan, USA.
authors.forename: David G
authors.initials: DG
authors.lastname: Frame
authors.affiliation: Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Health System and Medical School, Ann Arbor, Michigan, USA.
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Kaul
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D009181:Mycoses / Q000517:prevention & control*
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents